AMBER HUNT: Open Payments
NPI 1497051684 · CLINTON, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$537 in 26 payments from 10 companies in 2025. Trend: 2023 $202 · 2024 $345 · 2025 $537
Food & beverage: $437Education: $100
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 9 | $270 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $77 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $39 |
| SHIELD THERAPEUTICS INC | 2 | $36 |
| MILLICENT US INC | 1 | $24 |
| Biogen, Inc. | 1 | $22 |
| Organon LLC | 1 | $20 |
| Exeltis, USA Inc. | 1 | $19 |
| Hologic Sales and Service, LLC | 1 | $16 |
| Acella Pharmaceuticals, LLC | 1 | $14 |
Products named: Veozah, Mirena, ACCRUFER, INTRAROSA, ZURZUVAE, NEXPLANON, SLYND, APTIMA.
Industry payments across AR — which companies pay providers there.
